Company Description
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions.
The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions.
Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients.
The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus.
The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings.
The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector.
The company was founded in 2007 and is based in Austin, Texas.
| Country | United States |
| Founded | 2007 |
| IPO Date | May 8, 2026 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 167 |
| CEO | Richard Foust |
Contact Details
Address: 2802 Flintrock Trace, Suite 226 Austin, Texas 78738 United States | |
| Phone | (855) 628-9375 |
| Website | mobia.com |
Stock Details
| Ticker Symbol | MOBI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $15.00 |
| CIK Code | 1489993 |
| CUSIP Number | 60705V103 |
| ISIN Number | US60705V1035 |
| Employer ID | 20-8573833 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Richard Foust | President, Chief Executive Officer and Director |
| Nelson Bunker Curnes | Chief Financial Officer and Director |
| Douglas (Doug) Ellison | Chief Commercial Officer |
| Prashant Rawat | Chief Operating Officer |
| Thomas Jordan Curnes II | Co-Founder and Director |
| Chase Leavitt | General Counsel and Corporate Secretary |
| Dana G. Mead, Jr. | Chair of the Board |
| Casey Tansey | Director |
| William (Bill) Harrington | Director |
| Cynthia Lucchese | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 13, 2026 | SCHEDULE 13D | Filing |
| May 11, 2026 | 8-K | Current Report |
| May 8, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| May 8, 2026 | 424B4 | Prospectus |
| May 7, 2026 | EFFECT | Notice of Effectiveness |
| May 7, 2026 | CERT | Certification by an exchange approving securities for listing |
| May 7, 2026 | 8-A12B | Registration of securities |
| May 4, 2026 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Apr 27, 2026 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Apr 17, 2026 | S-1 | General form for registration of securities under the Securities Act of 1933 |